Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yuning Shi

Showing results (21-30 of 25) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 25 results.
Journal of Medicinal Chemistry|July 25, 2024
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic CancerShengnan Zhou, Xiaotong Ze, Dazhi Feng, et al.
Chemical Science|August 6, 2025
Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacyDazhi Feng, Xinnan Li, Junkai Liu, et al.
BMC Infectious Diseases|August 7, 2021
Increasing the HIV testing among MSM through HIV test result exchange mechanism: study protocol for a cluster randomized controlled trialYuning Shi, Jialing Qiu, Qingling Yang, et al.
Journal of Medicinal Chemistry|July 29, 2025
Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer TherapyXinnan Li, Lihua Liu, Dazhi Feng, et al.
Nature Geoscience|March 18, 2022
Confronting the water potential information gapKimberly A Novick, Darren L Ficklin, Dennis Baldocchi, et al.
Pageof 3

Showing results (21-30 of 25) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 25 results.
Journal of Medicinal Chemistry|July 25, 2024
Identification of 6-Fluorine-Substituted Coumarin Analogues as POLRMT Inhibitors with High Potency and Safety for Treatment of Pancreatic CancerShengnan Zhou, Xiaotong Ze, Dazhi Feng, et al.
Chemical Science|August 6, 2025
Selectively triggered: ROS-activated Michael acceptor prodrug strategy to enhance tumor targeting efficacyDazhi Feng, Xinnan Li, Junkai Liu, et al.
BMC Infectious Diseases|August 7, 2021
Increasing the HIV testing among MSM through HIV test result exchange mechanism: study protocol for a cluster randomized controlled trialYuning Shi, Jialing Qiu, Qingling Yang, et al.
Journal of Medicinal Chemistry|July 29, 2025
Design, Optimization, and Biological Evaluation of a Novel Quinoline-Based POLRMT Inhibitor for Prostate Cancer TherapyXinnan Li, Lihua Liu, Dazhi Feng, et al.
Nature Geoscience|March 18, 2022
Confronting the water potential information gapKimberly A Novick, Darren L Ficklin, Dennis Baldocchi, et al.
Pageof 3